-
-
-
-
-
-
-
Ophthotech Corp (OPHT) Appoints Calvin (Cal) W. Roberts MD to Board
-
-
-
-
-
-
-
Ophthotech Corp (OPHT) Tops Q3 EPS by 2c
-
-
-
-
-
-
-
Pre-Open Movers 06/07: (AVHI) (CONN) (FIVE) Higher; (MDXG) (PTI) (REVG) Lower (more...)
-
-
-
-
-
-
-
Ophthotech Announces First Patient Enrolled in the Phase 2b Clinical Trial of Zimura®, Complement C5 Inhibitor, for the Treatment of Autosomal Recessive Stargardt Disease (STGD1)
-
-
-
-
-
-
-
Ophthotech Corp (OPHT) CEO to Transition to Executive Chairman; Glenn P. Sblendorio Named CEO
-
-
-
-
-
-
-
Tech, bank shares slip after recent gains; health outperforms
-
-
-
-
1,157,743 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

